Novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid–nitric oxide (GIT-27NO) induces p53 mediated apoptosis in human A375 melanoma cells
Sanja Mijatović(University of Belgrade), Ferdinando Nicoletti(University of Catania), Massimo Libra(University of Catania), Marco Donia(University of Copenhagen), Graziella Malaponte(University of Catania), Ljubica Harhaji‐Trajkovic(University of Belgrade), Gianni Garotta(Roche (Switzerland)), Ylenia Bevelacqua(University of Catania), Darrin Dabideen, Kai Cheng(Chinese Academy of Sciences), Stanislava Stošić‐Grujičić(Institute for Biological Research “Siniša Stanković”), Marija Mojić(Northwell Health), Yousef Al‐Abed(Feinstein Institute for Medical Research), Danijela Maksimović‐Ivanić(Institute for Biological Research “Siniša Stanković”), Djordje Miljković(University of Belgrade), Venera Cardile(University of Catania)
Cited by 26
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium
|Frontiers in Pharmacology|2018|878
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508